Volker Ehemann
Has participated in:
-
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
-
Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
-
Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy
-
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy